Vaccination titres pre- and post-transplant in paediatric renal transplant recipients and the impact of immunosuppressive therapy.

Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-198X (Electronic) Linking ISSN: 0931041X NLM ISO Abbreviation: Pediatr Nephrol Subsets: MEDLINE

Publication: Berlin : Springer International
Original Publication: Berlin : Springer International, c1987-

Antibodies/*blood ; Immunosuppressive Agents/*adverse effects ; Kidney Transplantation/*adverse effects ; Vaccination/*methods ; Vaccines/*immunology; Child ; Cohort Studies ; Female ; Humans ; Male ; Registries ; Transplant Recipients ; Vaccination/statistics & numerical data

Background: Avoidance of vaccine-preventable infections in paediatric renal allograft recipients is of utmost importance. However, the development and maintenance of protective vaccination titres may be impaired in this patient population owing to their need for immunosuppressive medication.
Methods: In the framework of the Cooperative European Paediatric Renal Transplant Initiative (CERTAIN), we therefore performed a multi-centre, multi-national study and analysed vaccination titres pre- and post-transplant in 155 patients with serial titre measurements in comparison with published data in healthy children.
Results: The percentage of patients with positive vaccination titres before renal transplantation (RTx) was low, especially for diphtheria (38.5%, control 75%) and pertussis (21.3%, control 96.3%). As few as 58.1% of patients had a hepatitis B antibody (HBsAb) titre >100 IU/L before RTx. 38.1% of patients showed a vaccination titre loss post-transplant. Patients with an HBsAb titre between 10 and 100 IU/L before RTx experienced a significantly (p < 0.05) more frequent hepatitis B vaccination titre loss post-transplant than patients with an HBsAb titre >100 IU/L. The revaccination rate post-transplant was low and revaccination failed to induce positive titres in a considerable number of patients (27.3 to 83.3%). Treatment with rituximab was associated with a significantly increased risk of a vaccination titre loss post-transplant (odds ratio 4.26, p = 0.033).
Conclusions: These data show a low percentage of patients with positive vaccination titres pre-transplant, a low revaccination rate post-transplant with limited antibody response, and a high rate of vaccination titre losses.

Am J Transplant. 2010 Mar;10(3):464-71. (PMID: 20121738)
Transplantation. 1997 Jul 27;64(2):237-41. (PMID: 9256180)
Hum Vaccin Immunother. 2017 Mar 4;13(3):661-675. (PMID: 27736293)
Clin Microbiol Infect. 2016 Dec 1;22 Suppl 5:S89-S95. (PMID: 27130670)
Transpl Int. 2017 Jul;30(7):689-694. (PMID: 28346714)
Eur J Pediatr. 2012 Mar;171(3):463-70. (PMID: 21935584)
Exp Clin Transplant. 2010 Mar;8(1):19-28. (PMID: 20199367)
Clin Infect Dis. 2013 Jan;56(1):84-92. (PMID: 23042966)
Curr Infect Dis Rep. 2015 Apr;17(4):472. (PMID: 25870140)
J Pediatr. 1997 Jun;130(6):987-9. (PMID: 9202624)
Pediatr Nephrol. 2018 Feb;33(2):341-350. (PMID: 28983694)
Exp Clin Transplant. 2012 Aug;10(4):314-8. (PMID: 22845763)
Pediatr Nephrol. 1992 Mar;6(2):187-9. (PMID: 1571219)
Am J Kidney Dis. 2002 Aug;40(2):365-72. (PMID: 12148110)
Clin J Am Soc Nephrol. 2017 May 8;12 (5):772-778. (PMID: 28270432)
Pediatr Transplant. 2012 Nov;16(7):699-703. (PMID: 22805334)
Kidney Int. 2010 Feb;77(4):299-311. (PMID: 19847156)
Am J Transplant. 2013 Mar;13 Suppl 4:311-7. (PMID: 23465023)
Clin Vaccine Immunol. 2015 Mar;22(3):282-90. (PMID: 25540274)
Am J Transplant. 2006 Mar;6(3):565-8. (PMID: 16468967)
Am J Transplant. 2009 Nov;9 Suppl 3:S1-155. (PMID: 19845597)
Pediatrics. 2005 Jul;116(1):160-7. (PMID: 15995047)
Transplant Proc. 2013 May;45(4):1414-7. (PMID: 23726585)
Pediatr Nephrol. 2012 Aug;27(8):1257-63. (PMID: 22048175)
Pediatr Transplant. 2007 Feb;11(1):73-6. (PMID: 17239126)
Am J Transplant. 2007 Mar;7(3):633-8. (PMID: 17217436)
Vaccine. 2013 May 7;31(20):2420-6. (PMID: 23583889)
Transplantation. 2012 Dec 15;94(11):e69-71. (PMID: 23222744)
Clin J Am Soc Nephrol. 2011 May;6(5):1094-9. (PMID: 21393491)
Pediatr Infect Dis J. 2009 Aug;28(8):688-92. (PMID: 19633514)
J Infect Dis. 1999 Dec;180(6):2014-7. (PMID: 10558960)
Pediatr Transplant. 2009 Dec;13(8):1007-13. (PMID: 19207222)
Pediatr Infect Dis J. 2007 Aug;26(8):705-10. (PMID: 17848882)
Pediatr Infect Dis J. 2015 Apr;34(4):e85-91. (PMID: 25389920)
Kidney Int. 1999 Feb;55(2):713-23. (PMID: 9987096)
Clin Infect Dis. 2001 Jul 1;33(1):16-21. (PMID: 11389489)
Adv Perit Dial. 1999;15:269-72. (PMID: 10682116)
Vaccine. 1999 Jun 4;17(20-21):2507-11. (PMID: 10418896)
Pediatr Transplant. 1999 May;3(2):109-14. (PMID: 10389132)
Pediatr Transplant. 2005 Apr;9(2):192-6. (PMID: 15787792)
Vaccine. 2013 Jan 2;31(2):387-93. (PMID: 23142306)
Transplantation. 2008 Dec 15;86(11):1531-5. (PMID: 19077885)
Pediatr Infect Dis J. 2016 Jul;35(7):e206-19. (PMID: 27097348)
Infection. 2012 Jun;40(3):299-302. (PMID: 22173948)
Pediatr Transplant. 2005 Apr;9(2):183-6. (PMID: 15787790)
J Clin Virol. 2015 Jul;68:32-6. (PMID: 26071332)
Vaccine. 2015 Aug 26;33(36):4579-85. (PMID: 26165918)
J Am Soc Nephrol. 2009 Mar;20(3):629-37. (PMID: 19158356)
Pediatr Transplant. 2005 Oct;9(5):652-61. (PMID: 16176426)
Pediatr Nephrol. 2002 Aug;17(8):638-42. (PMID: 12185473)
Vaccine. 1995 Nov;13(16):1611-6. (PMID: 8578850)
Vaccine. 1995 Jun;13(9):799-802. (PMID: 7483800)

Keywords: Hepatitis B; Paediatric; Renal transplantation; Rituximab; Vaccination; Vaccination titre

0 (Antibodies)
0 (Immunosuppressive Agents)
0 (Vaccines)

Date Created: 20180112 Date Completed: 20190612 Latest Revision: 20190613

20221213

10.1007/s00467-017-3868-0

29322328